Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

104.05 -2.89 (-2.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
1 Super Growth Stock Down 63% to Buy Hand Over Fist in 2025
Via The Motley Fool
"Rule Breaker Investing" Mailbag: Portfolio-Level Thinking
From a preschool teacher newly inspired to invest at 73 to a lifelong Fool whose Microsoft shares became a 500-bagger, this year-end mailbag edition brims with transformational stories. 
Via The Motley Fool
StoryTrading's Secrets To January Gains - Don’t Miss These Picks
As we usher in the new year, market dynamics continue to be shaped by a blend of tax-deferral selling, the January effect, and macro uncertainties. 
Via Talk Markets
Topics Stocks / Equities
Here's How Much You Would Have Made Owning TransMedics Gr Stock In The Last 5 Years
 
Via Benzinga
10 Overlooked Stocks Set to Soar in 2025
All 10 underperformed in 2024, but I believe they'll turn things around in 2025. 
Via The Motley Fool
Looking Into TransMedics Gr's Recent Short Interest
 
Via Benzinga
$100 Invested In TransMedics Gr 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Is TransMedics Stock a Buy Before 2025?
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Beyond The Numbers: 13 Analysts Discuss TransMedics Gr Stock
 
Via Benzinga
2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid
Via The Motley Fool
$1000 Invested In TransMedics Gr 5 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Down Over 60%, Is TransMedics Stock a Buy on the Dip?
Via The Motley Fool
Why Transmedics Group Stock Plummeted 21% This Week
Via The Motley Fool
Why TransMedics Stock Plummeted Today
Via The Motley Fool
Behind the Scenes of TransMedics Gr's Latest Options Trends
 
Via Benzinga
TransMedics Ushers In New CFO, Tightens 2024 Revenue Goals
TransMedics Group appoints new CFO, Gerardo Hernandez, and adjusts financial outlook for 2024. 
Via Benzinga
3 Cheap Stocks to Buy Now
Three stocks poised for upside, both near-term and long-term. 
Via The Motley Fool
Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
1 Top Growth Stock Down 56% to Buy After Its Recent Pullback
This growth stock has been on my watchlist for a while and might soon be included in my portfolio. 
Via The Motley Fool
Looking Into TransMedics Gr's Recent Short Interest
 
Via Benzinga
Navigating 11 Analyst Ratings For TransMedics Gr
 
Via Benzinga
2 Hypergrowth Stocks That Are Screaming Buys in November
Via The Motley Fool
This HCA Healthcare Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
 
Via Benzinga
Jim Cramer Likes Devon Energy, But Calls Another Stock 'Far Superior'
Amphenol (APH) is a terrific stock, reporting better-than-expected earnings, while Cramer prefers CTRA over DVN and doesn't see potential in TMDX. 
Via Benzinga
Is TransMedics Group Stock a Buy?
This organ transplant specialist is down, but still has plenty of signs of life. 
Via The Motley Fool
Down 52%, Is TransMedics Stock a Buy on the Dip?
Sales growth is tapering off for this provider of delivery services for transplant organs. 
Via The Motley Fool
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into TransMedics Group, Inc. (NASDAQ: TMDX)
From Scott+Scott Attorneys at Law LLP
Via Business Wire
Why TransMedics Stock Plunged in October
The organ transplant specialist posted disappointing results in its third-quarter report. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.